• 1
    Timar J,Lapis K,Dudas J,Sebestyen A,Kopper L,Kovalszky I. Proteoglycans and tumor progression: Janus-faced molecules with contradictory functions in cancer. Semin Cancer Biol 2002; 12: 17386.
  • 2
    Valla S,Li J,Ertesvag H,Barbeyron T,Lindahl U. Hexuronyl C5-epimerases in alginate and glycosaminoglycan biosynthesis. Biochimie 2001; 83: 81930.
  • 3
    Westergren-Thorsson G,Onnervik PO,Fransson LA,Malmstrom A. Proliferation of cultured fibroblasts is inhibited by L-iduronate-containing glycosaminoglycans. J Cell Physiol 1991; 147: 52330.
  • 4
    Westergren-Thorsson G,Persson S,Isaksson A,Onnervik PO,Malmstrom A,Fransson LA. L-iduronate-rich glycosaminoglycans inhibit growth of normal fibroblasts independently of serum or added growth factors. Exp Cell Res 1993; 206: 939.
  • 5
    Syrokou A,Tzanakakis G,Tsegenidis T,Hjerpe A,Karamanos NK. Effects of glycosaminoglycans on proliferation of epithelial and fibroblast human malignant mesothelioma cells: a structure-function relationship. Cell Prolif 1999; 32: 8599.
  • 6
    Nikitovic D,Zafiropoulos A,Tzanakakis GN,Karamanos NK,Tsatsakis AM. Effects of glycosaminoglycans on cell proliferation of normal osteoblasts and human osteosarcoma cells depend on their type and fine chemical compositions. Anticancer Res 2005; 25: 28516.
  • 7
    Tsara ME,Theocharis AD,Theocharis DA. Compositional and structural alterations of proteoglycans in human rectum carcinoma with special reference to versican and decorin. Anticancer Res 2002; 22: 28938.
  • 8
    Theocharis AD,Vynios DH,Papageorgakopoulou N,Skandalis SS,Theocharis DA. Altered content composition and structure of glycosaminoglycans and proteoglycans in gastric carcinoma. Int J Biochem Cell Biol 2003; 35: 37690.
  • 9
    Theocharis AD. Human colon adenocarcinoma is associated with specific post-translational modifications of versican and decorin. Biochim Biophys Acta 2002; 1588: 16572.
  • 10
    Skandalis SS,Kletsas D,Kyriakopoulou D,Stavropoulos M,Theocharis DA. The greatly increased amounts of accumulated versican and decorin with specific post-translational modifications may be closely associated with the malignant phenotype of pancreatic cancer. Biochim Biophys Acta 2006; 1760: 121725.
  • 11
    Skandalis SS,Theocharis AD,Papageorgakopoulou N,Vynios DH,Theocharis DA. The increased accumulation of structurally modified versican and decorin is related with the progression of laryngeal cancer. Biochimie 2006; 88: 113543.
  • 12
    Li J,Hagner-McWhirter A,Kjellen L,Palgi J,Jalkanen M,Lindahl U. Biosynthesis of heparin/heparan sulfate. cDNA cloning and expression of D-glucuronyl C5-epimerase from bovine lung. J Biol Chem 1997; 272: 2815863.
  • 13
    Li JP,Gong F,El Darwish K,Jalkanen M,Lindahl U. Characterization of the D-glucuronyl C5-epimerase involved in the biosynthesis of heparin and heparan sulfate. J Biol Chem 2001; 276: 2006977.
  • 14
    Crawford BE,Olson SK,Esko JD,Pinhal MA. Cloning, Golgi localization, and enzyme activity of the full-length heparin/heparan sulfate-glucuronic acid C5-epimerase. J Biol Chem 2001; 276: 2153843.
  • 15
    Maccarana M,Olander B,Malmström J,Tiedemann K,Aebersold R,Lindahl U,Li JP,Malmström A. Biosynthesis of dermatan sulfate: chondroitin-glucuronate C5-epimerase is identical to SART2. J Biol Chem 2006; 281: 115608.
  • 16
    Lindahl U,Bäckström G,Malmström A,Fransson LA. Biosynthesis of L-iduronic acid in heparin: epimerization of D-glucuronic acid on the polymer level. Biochem Biophys Res Commun 1972; 46: 985991.
  • 17
    Jacobsson I,Lindahl U,Jensen JW,Roden L,Prihar H,Feingold DS. Biosynthesis of heparin. Substrate specificity of heparosan N-sulfate D-glucuronosyl 5-epimerase. J Biol Chem 1984; 259: 105663.
  • 18
    Hagner-McWhirter A,Li JP,Oscarson S,Lindahl U. Irreversible glucuronyl C5-epimerization in the biosynthesis of heparan sulfate. J Biol Chem 2004; 279: 146318.
  • 19
    Li JP,Gong F,Hagner-McWhirter A,Forsberg E,Abrink M,Kisilevsky RX,Zhang X,Lindahl U. Targeted disruption of a murine glucuronyl C5-epimerase gene results in heparan sulfate lacking L-iduronic acid and in neonatal lethality. J Biol Chem 2003; 278: 283636.
  • 20
    Li J,Wang F,Protopopov A,Malyukova A,Kashuba V,Minna JD,Lerman MI,Klein G,Zabarovsky E. Inactivation of RASSF1C during in vivo tumor growth identifies it as a tumor suppressor gene. Oncogene 2004; 23: 59419.
  • 21
    Lung HL,Bangarusamy DK,Xie D,Cheung AK,Cheng Y,Kumaran MK,Miller L,Liu ET,Guan XY,Sham JS,Fang Y,Li L et al. THY1 is a candidate tumour suppressor gene with decreased expression in metastatic nasopharyngeal carcinoma. Oncogene 2005; 24: 652532.